Elite Pharmaceuticals Acquires Trimipramine ANDA
May 22, 2017 20:12 pm UTC| Business
NORTHVALE, N.J., May 22, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application (“ANDA”) for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...